Stocks Health care NCNA
NASDAQ · Health careNuCana plc (NCNA)
It posted a net loss of £29.4M. In fiscal 2025 capital spending exceeded operating cash flow by £7.5M. At December 31, 2025 it held £24.3M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 19, 2026.
Key facts about NuCana plc
- Net worth
- NuCana plc has a market value (market cap) of $4M at the latest share price, and shareholders' equity of £24.3M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used £7.5M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 19, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What NuCana plc does
NuCana plc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NCNA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -£29.4M | £0.00 | -£7.5M |
| 2024 | n/a | -£19M | -£0.26 | -£19.1M |
| 2023 | n/a | -£27.6M | -£0.53 | -£26.4M |
| 2022 | n/a | -£32M | -£0.61 | -£23.2M |
| 2021 | n/a | -£40.5M | -£0.78 | -£23.9M |
| 2020 | n/a | -£30.7M | -£0.81 | -£22M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What NuCana plc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 30, 2026
- August 13, 2026
- June 8, 2026
- June 1, 2026
- May 14, 2026
- May 6, 2026
- March 19, 2026
- March 19, 2026
- March 19, 2026
- March 18, 2026Activist stake (5% or more) SCHEDULE 13D
Insider trades
What the people running NuCana plc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns NCNA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Hugh S. Griffith13D, may seek influence | 12% | March 18, 2026 |
| Dr. James I. Healy ("Healy")13D, may seek influence with 6 related filers | 11.9% | February 27, 2024 |
| Sofinnova Capital VI FCPR13D, may seek influence with 7 related filers | 5.1% | February 14, 2025 |
Largest institutional holders
Insiders
Questions about NCNA
What does NuCana plc do?
NuCana plc is a company in the Health care sector, listed on NASDAQ as NCNA. Its shares trade on NASDAQ under the ticker NCNA.
What is NuCana plc's net worth?
NuCana plc has a market value (market cap) of $4M at the latest share price, and shareholders' equity of £24.3M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is NuCana plc profitable?
No. In fiscal 2025 it reported a net loss of £29.4M.
When did NuCana plc last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 19, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 30, 2026.
Similar companies
Compare NCNA with
Follow NCNA
Get an email when NuCana plc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values NuCana plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.